EIF2AK2 and neoplasm: Oncolytic γ34.5 gene deleted HSV was complemented by two different PKR-antagonists from human cytomegalovirus, TRS1 and IRS1, generating a chimera capable of reaching wild type virus replication levels in cancer cells in vitro and in tumor models in vivo [158].